SPATA48: A Drug Target / Disease Biomarker (G100130988)

Target Name: SPATA48

NCBI ID: G100130988

SPATA48

SPATA48: A Drug Target / Disease Biomarker

SPATA48 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and biology have made it an attractive target for researchers to study and potentially develop new treatments.

SPATA48 is a small RNA molecule that is approximately 200 amino acids long. It is expressed in most tissues and cells in the body and is involved in a variety of cellular processes, including gene regulation, DNA replication, and RNA translation. SPATA48 is typically expressed in the cytoplasm of eukaryotic cells and is localize to the nuclear envelope.

One of the key features of SPATA48 is its ability to interact with other molecules in the cell. It has been shown to interact with a variety of proteins, including the transcription factor ASXL1 and the protein tyrosine phosphatase PAK4. These interactions may play a role in the regulation of cellular processes such as cell growth, apoptosis, and transcriptional output.

SPATA48 has also been shown to be involved in a variety of diseases and disorders. For example, it has been associated with a variety of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. It has also been shown to be involved in cancer, including breast cancer and colorectal cancer.

In addition to its potential as a drug target, SPATA48 has also been identified as a potential biomarker. Its expression has been shown to be altered in a variety of diseases and conditions, including neurodegenerative diseases, cancer, and autoimmune disorders. This may make it an useful tool for the diagnosis and treatment of these diseases.

SPATA48 is also a good candidate for a new drug development program. Its unique structure and biology make it different from most other molecules, which may make it more stable and less likely to cause unintended side effects. Additionally, its interactions with other molecules in the cell make it more complex, which may make it more difficult to target than simpler molecules.

In conclusion, SPATA48 is a promising drug target and biomarker for a variety of diseases. Its unique structure and biology make it an attractive target for researchers to study and develop new treatments. Further research is needed to fully understand its role in cellular processes and its potential as a drug and biomarker.

Protein Name: Spermatogenesis Associated 48

Functions: Essential for normal spermatogenesis

The "SPATA48 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPATA48 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets